BioIQ is modernizing the diagnostic testing industry through a national network of labs and customized solutions that support payors, employers, and consumers. By aggregating testing solutions, optimizing lab capacity, and integrating testing with customers’ needs and strategies, BioIQ ensures resilience and reliability so that employers and payors can protect workforces and members.
With its first-of-its-kind health connectivity platform, BioIQ is uniquely positioned at the convergence of population health and the consumerization and retailization of healthcare to drive the shift to value-based care for payers and employers. Since 2005, BioIQ has launched thousands of successful health testing programs serving millions of participants.
Founded: 2005
Industry: Diagnostic
Size: +300 employees
Headquarters: Atlanta, GA
Website: www.bioiq.com
Related Articles
Bellante Wins Entrepreneur Of The Year® 2022 Southeast
BioIQ has won a number of awards over the summer: BioIQ Earns Inc. 5000 Status with 573% 3-Year Growth
Entrepreneurship Speaker Series: Justin Bellante (CWR ’01), Founder & CEO at BioIQ
In August 2022, Justin Bellante (CWR ’01) participated in a Case Western Reserve University Entrepreneurship Speaker Series hosted by Michael Goldberg, Executive Director of the Veale Institute for Entrepreneurship. The Veale Institute for Entrepreneurship hosts...
BioIQ Listed in the Top 100 Healthcare Technology Companies of 2022
The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2022. The awardees on this year’s list represent the absolute best in the healthcare technology space. From companies like Novartis with more than 100,000 team...
BioIQ’s Justin Bellante won EY Entrepreneur Of The Year 2022 Southeast Award
Finalists were selected by a panel of independent judges based on their demonstration of long-term value through entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes. Regional award winners will be announced in June 2022. +...